Ozempic (semaglutide) is an FDA-approved medication primarily used for managing Type 2 diabetes and supporting weight management. It belongs to a class of medications called GLP-1 receptor agonists.
Gradual and sustainable weight loss
Reduced appetite and portion control
Changes in eating habits and food preferences
Combined benefits with exercise and healthy diet
Initial adjustment period with gradual dose increases. Users often report early signs of appetite reduction.
Starting Phase
Most users see significant changes in eating habits and potential weight loss begins to show.
Adjustment Phase
Sustained results with continued use, focusing on lifestyle changes and healthy habits.
Maintenance Phase
Gradual and sustainable weight loss
Reduced appetite and portion control
Changes in eating habits and food preferences
Combined benefits with exercise and healthy diet
